Senators Draw a Line on Hemp Language
Two Republican senators say they will not support passage of any bill to keep the federal government funded if it includes language to reverse the currently scheduled recriminalization of hemp THC products.
The bill, filed by Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN), is the Hemp Guardrails Act. Industry advocates hope the measure can be attached to larger, must-pass appropriations legislation.
What the Senators Said
Budd said in a social media post that he “will not support any year-end package that extends, delays, or builds a regulatory framework around products that fuel addiction, endanger our children, and weaken our workforce.” He said Congress closed the hemp loophole more than a year ago to end an industry that never should have existed.
Budd added that he has heard from countless constituents whose loved ones’ addictions began with the very products the Sheehy-Klobuchar bill would legalize at even higher, more dangerous potency. Ricketts, another outspoken opponent of cannabis reform, said on Tuesday that he agrees with Budd. “I won’t support any legislation that allows these drugs to continue hurting our kids and communities,” he said in a social media post.
What the Bill Would Do
The Hemp Guardrails Act would stop the ban scheduled to go into effect next month while instituting new product rules as an alternative to prohibition. It would raise the legal threshold for hemp to one percent total THC on a dry-weight basis, with an exception to go above that for in-process materials.
The measure would create a new category of prohibited cannabinoids including delta-8 THC, delta-10 THC and THC-O-acetate, while restricting the manufacturing or synthesizing of those compounds outside of the hemp plant. It would set an age limit of 21 to possess and consume hemp cannabinoid products, and products would need to be grown, processed and packaged within the U.S. to be legal.
The bill also directs the FDA to set rules for packaging, labeling, manufacturing, testing, registration and recalls within 180 days. Budd had tried unsuccessfully to get delay language removed from the funding bill Trump signed in September, which pushed the ban’s effective date back to December 11 for most products.

